🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of the study is to assess safety, tolerability and clinical effects...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01784562
Treatments Being Tested
This study was designed to evaluate the safety, tolerability, pharmacodynam...
Status
Active Not Recruiting
Location
Clínica Imbanaco S.A.S
Start Date
2015-10-29
Trial ID
NCT02562235
Treatments Being Tested
To provide riociguat therapy to eligible patients with PAH originating from...
Status
Completed
Location
Multiple Locations
Start Date
2016-06-16
Trial ID
NCT02759419
Treatments Being Tested
Patients who have completed the 12 weeks treatment of the PATENT-1 trial (s...
Status
Completed
Location
Multiple Locations
Start Date
2009-03-12
Trial ID
NCT00863681
Treatments Being Tested
To demonstrate the effectiveness of riociguat as replacement of phosphodies...
Status
Completed
Location
Multiple Locations
Start Date
2017-01-11
Trial ID
NCT02891850
Treatments Being Tested
To investigate if Riociguat is effective in the treatment of systemic scler...
Status
Completed
Location
Mayo Clinic - Scottsdale
Start Date
2015-01-15
Trial ID
NCT02283762
Treatments Being Tested
This is a study to demonstrate the feasibility of an individual dose titrat...
Status
Completed
Location
Multiple Locations
Start Date
2007-01
Trial ID
NCT00454558
Treatments Being Tested
To investigate relative bioavailability of crushed tablets suspended in app...
Status
Completed
Location
Multiple Locations
Start Date
2014-06
Trial ID
NCT02159313
Treatments Being Tested
To evaluate the efficacy and safety of 26-weeks of treatment with riociguat...
Status
Terminated
Location
University of California, Los Angeles
Start Date
2014-06-04
Trial ID
NCT02138825
Treatments Being Tested
BAY63-2521 Riociguat leads to the relaxation of smooth muscle cells in pulm...
Status
Completed
Location
Multiple Locations
Start Date
2014-02-18
Trial ID
NCT02007629
Treatments Being Tested